Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering the next generation of biotech leaders, today announced its newest Core and Associate chapters. The Core chapters are Israel, Denmark, Germany, and Florida; the Associate chapters are Singapore, Pittsburgh, Arizona, and the Baltics.
A Global Biotechnology Network
With the expansion of Nucleate into new regions, the organization aims to bridge geographical chasms and connect biotechnologists from diverse backgrounds. The addition of these chapters also provides a platform for local ecosystems, supporting career development and collaboration.
“Nucleate has a unique opportunity to empower a generation of biotechnologists and integrate scientific disciplines. Endorsed by Israel’s Bio-Convergence Initiative, they are imbuing technology development with a new strategic lens and a connected global community,” said Dana Gourevich, CTO of the Israeli Innovation Authority.
“As a founder of an international chapter, I have personally witnessed the vital role Nucleate plays in local ecosystems. These chapters have already become pillars of their communities. We gratefully support these critical bridges between academia and industry,” said Liyam Chitayat Levi, EVP Global Strategy at Nucleate and incoming PhD student at MIT.
Nucleate regional chapters engage in a range of initiatives: conferences, hackathons, speaker panels, mentorship programs, and networking events. These activities bolster local biotech by connecting academic trainees, senior faculty, investors, founders, and other stakeholders. Such regional entities are called Associate Chapters.
As the Associate Chapters progress, they attain Core chapter status. At this milestone, they manage the complete range of Nucleate’s programs, including the Activator program, the equity-free, in-depth curriculum aimed at life science venture creation for applications to human health and environmental sustainability.
New Chapters Led by Scientists
Nucleate is excited to welcome new Core chapters, located in Israel, Denmark, Germany, and Florida. These chapters have successfully engaged with their respective biotech community at scale, pioneering a wide range of educational programs.
“Despite our small country, we’ve made a significant impact through our vibrant community, in Israel and globally. Collaboration drives progress, and we’re thrilled to be part of this dynamic network,” said Romi Goldner, Co-Managing Director of Nucleate Israel and Ph.D. student at Bar Ilan University.
“Joining Nucleate as the Florida chapter has allowed us to bridge the gap between academia and the biotech industry. We’re connecting our community to a diverse and global network of like-minded individuals,” said Natalie Ricciardi, Co-Managing Director of Nucleate Florida and Ph.D. candidate at the University of Miami.
Those chapters are accompanied by the incoming class of four Associate chapters based in Singapore, Pittsburgh, Arizona, and the Baltics.
“We are thrilled that Nucleate is strongly contributing to the development of the Baltics, one of the fastest emerging regions in the world. We will work closely with our partners and stakeholders to realize this dynamic region’s full potential,” said Nemira Zilinskaite, Co-Managing Director of Nucleate Baltics and Ph.D. candidate at the University of Cambridge.
“Every corner of the globe should be able to access world-class biotech education. Our new chapter leaders are champions for our mission of democratizing biotechnology,” said Michael Retchin, Nucleate Co-President and Ph.D. candidate at Weill Cornell.
With 23 chapters and participation from over 150 academic institutions globally, Nucleate identifies future biotech entrepreneurs, removes barriers, and helps founders concentrate on building transformational technologies. It is the largest biotechnology organization of its kind, commited to fostering a global community and providing open access to biotech education. Nucleate is supported by premier advisors, partners, and sponsors. Email firstname.lastname@example.org to get involved.
Nucleate’s programs are made possible thanks to our generous sponsors: (platinum) Alnylam, Genentech, Eli Lilly, Millipore Sigma, Pillar VC and BlueYard Capital; (gold) Alexandria LaunchLabs; (silver) Qiagen, Schrodinger, Cromatic; and philanthropic support from Schmidt Futures and Lyda Hill Philanthropies. For regional sponsors and more information, visit www.nucleate.xyz.